Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2021 - 2026)

Aurinia Pharmaceuticals (AUPH) has 5 years of Amortizatization of Intangibles data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 12.69% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 19.2% YoY) and the FY2025 annual result came in at $10.2 million, down 20.05% from the prior year.
• Amortizatization of Intangibles declined to $2.3 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.4 million in Q3 2024 to a low of -$211000.0 in Q2 2022.
• A 5-year average of $2.3 million and a median of $2.6 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 1965.0% — and 2025, when it declined 23.27%.
• Tracing AUPH's Amortizatization of Intangibles over 5 years: stood at $1.6 million in 2022, then soared by 112.13% to $3.3 million in 2023, then fell by 9.86% to $3.0 million in 2024, then slipped by 21.62% to $2.3 million in 2025, then decreased by 0.69% to $2.3 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.